Trial intelligence / Profile preview

ACROBAT: Effect of Caffeine on Cold-stimulated BAT Activity

NCT06978777Completed

Sponsor
University Hospital Basel
Start
Jan 2026
Primary completion
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of caffeine (2 arms), sponsored by University Hospital Basel. Primary endpoint: Brown Adipose Tissue Standardized Uptake Value mean at 30 months. Started Jan 2026; status: completed.

02

Drugs

caffeine

Beyond the preview

Go deeper on NCT06978777.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06978777.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call